Inveltys (Loteprednol 1%)

IOP elevation and glaucoma: Prolonged corticosteroid use may produce glaucoma with optic nerve damage and defects in visual acuity and visual fields; use with caution in the presence of glaucoma and monitor IOP if the product is used 10 days or longer.

Posterior subcapsular cataract: Corticosteroid use may produce it.

Delayed healing after cataract surgery: Steroids may delay healing and increase the incidence of bleb formation.

Corneal or scleral perforation: In diseases causing thinning of the cornea or sclera, perforations have occurred with topical steroids.

Prescription renewal: The initial prescription and renewal only after examination with magnification such as slit lamp biomicroscopy and, where appropriate, fluorescein staining. This label sets no day count for the gate.

Secondary ocular infection: Prolonged use may suppress host response and increase the hazard of secondary ocular infection; in acute purulent conditions of the eye steroids may mask infection or enhance existing infection.

Viral infection exacerbation: Ocular steroids may prolong the course and worsen the severity of many ocular viral infections including herpes simplex; a history of herpes simplex requires great caution.

Fungal keratitis: Fungal corneal infection is particularly prone to develop coincidentally with long-term local steroid use; consider fungal invasion in any persistent corneal ulceration where a steroid has been used or is in use, and culture when appropriate.

Soft contact lenses: Remove lenses before instillation; the benzalkonium chloride 0.01% preservative may be absorbed by soft lenses, which may be reinserted 15 minutes after administration.